Skip to main content
Log in

Z-score is a possible predictor of the risk of coronary artery lesion development in patients with Kawasaki disease in Japan

  • Original Article
  • Published:
European Journal of Pediatrics Aims and scope Submit manuscript

Abstract

Risk factors for coronary artery lesion (CAL) development in patients with Kawasaki disease (KD) include male sex, age < 12 months, intravenous immunoglobulin (IVIG) resistance, and delayed diagnosis.. We aimed to explore the relationship between CAL development and Z-score. We enrolled 281 patients with KD who were treated with our protocol. Echocardiography was performed in three phases: pre-treatment (P1), post-treatment (P2), and 4 weeks after onset (P3). The highest Z-score of the right, left main, left anterior descending, and left circumflex coronary arteries was expressed as Zmax at each phase. P3-Zmax ≥ 2.5 represented CAL development. Clinical parameters, such as laboratory data and Z-scores, were retrospectively compared between patients with and without CAL development. Sixty-seven patients (23.8%) showed a P1-Zmax ≥ 2.0, and CAL development occurred in 21 patients (7.5%). Independent risk factors associated with CAL development were P1-Zmax, a ΔZmax (P2-Zmax − P1-Zmax) ≥ 1, male sex, < 12 months of age, and resistant to the first intravenous immunoglobulin (IVIG) administration (adjusted odds ratio [95% confidence interval]: 198 [1.01–3.92], 4.04 [1.11–14.7], 6.62 [1.33–33.04], 4.71 [1.51–14.68], 5.26 [1.62–17.13], respectively). Using receiver operating characteristic curve analysis, a P1-Zmax ≥ 1.43 detected CAL development with an area under the curve of 0.64 (sensitivity = 81.0%; specificity = 48.1%).

Conclusion: Our results suggest that P1-Zmax and a ΔZmax (P2-Zmax − P1-Zmax) ≥ 1 may predict CAL development.

What is Known:

KD is an acute vasculitis predominantly affecting the coronary artery of young children.

Although P1 Z-max ≥ 2.0 has been a predictor of CAL development, it has not yet been shown in Japan.

What is New:

P1-Zmax and a ΔZmax ≥ 1 are presumably associated with CAL development.

In the ROC curve analysis, P1-Zmax ≥ 1.43 detected CAL development, a sensitivity (81%) and a specificity (48%). We need to consider intensified initial therapy for patients with these risk factors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

Data availability

N/A

Code availability

N/A

Abbreviations

CAL:

Coronary artery lesion

CsA:

Cyclosporin A

IVIG:

Intravenous immunoglobulin

KD:

Kawasaki disease

LAD:

Left anterior descending artery

LCX:

Left circumflex artery

LMCA:

Left main coronary artery

P1:

Pre-treatment phase (at the time of KD diagnosis or before IVIG treatment)

P2:

Post-treatment phase (after first IVIG treatment and around 10 days from KD onset)

P3:

The convalescent phase (around 4 weeks from KD onset)

RCA:

Right coronary artery

Zmax:

The highest Z-score of four segments of coronary artery

ΔZmax:

Difference between P2-Zmax and P1-Zmax

References

  1. Kawasaki T (1967) Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of fingers and toes in children: clinical observation of 50 cases. Jpn J Allergol 16:178–222 (in Japanese)

    CAS  Google Scholar 

  2. Honkanen VEA, McCrindle BW, Laxer RM, Feldman BM, Schneider R, Silverman ED (2003) Clinical relevance of the risk factors for coronary artery inflammation in Kawasaki disease. Pediatr Cardiol 24:122–126

    Article  CAS  Google Scholar 

  3. Belay ED, Maddox RA, Holman RC, Curns AT, Ballah K, Schonberger LB (2006) Kawasaki syndrome and risk factors for coronary artery abnormalities: United States, 1994–2003. Pediatr Infect Dis J 25:245–249

    Article  Google Scholar 

  4. Song DI, Yeo Y, Ha KS, Jang GY, Lee JH, Lee KC, Son CS, Lee JW (2009) Kawasaki disease-associated coronary abnormalities differ depending on age. Eur J Pediatr 168:1315–1321

    Article  Google Scholar 

  5. Kim T, Choi W, Woo C-W, Choi B, Lee J, Lee K, Son C, Lee J (2007) Predictive risk factors for coronary artery abnormalities in Kawasaki disease. Eur J Pediatr 166:421–425

    Article  Google Scholar 

  6. Nakamura Y, Yashiro M, Uehara R, Sadakane A, Tsuboi S, Aoyama Y, Kotani K, Tsogzolbaatar EO, Yanagawa H (2012) Epidemiologic features of Kawasaki disease in Japan: results of the 2009-2010 nationwide survey. J Epidemiol 22:216–221

    Article  Google Scholar 

  7. Kobayashi T, Saji T, Otani T, Takeuchi K, Nakamura T, Arakawa H, Kato T, Hara T, Hamaoka K, Ogawa K et al (2012) Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label, blinded-endpoints trial. Lancet 379:1613–1620

    Article  CAS  Google Scholar 

  8. Hamada H, Suzuki H, Onouchi Y, Ebata R, Terai M, Fuse S, Okajima Y, Kurotobi S, Hirai K, Soga T, Ishiguchi Y, Okuma Y, Takada N, Yanai M, Sato J, Nakayashiro M, Ayusawa M, Yamamoto E, Nomura Y, Hashimura Y, Ouchi K, Masuda H, Takatsuki S, Hirono K, Ariga T, Higaki T, Otsuki A, Terauchi M, Aoyagi R, Sato T, Fujii Y, Fujiwara T, Hanaoka H, Hata A, Hamada H, Honda T, Yasukawa K, Hirai K, Takahiro N, Soga T, Yajima H, Ooto H, Umeda Y, Suzuki H, Takeuchi T, Suenaga T, Kakimoto N, Ishiguchi Y, Kamada M, Okuma Y, Takada N, Suwabe S, Yanai M, Ueno Y, Nishi N, Sato J, Saito Y, Kitani Y, Nakayashiro M, Nabeshima T, Takefuta K, Ayusawa M, Nakamura T, Komori A, Kato M, Ebata R, Saito N, Okunushi K, Kobayashi H, Yamamoto E, Nakano T, Nomura Y, Masuda K, Hashimura Y, Minami H, Uchiyama T, Okizuka Y, Ouchi K, Ohno N, Ogita S, Masuda H, Ono H, Ishiguro A, Takatsuki S, Saji T, Ichida F, Hirono K, Ozawa S, Ariga T, Takeda A, Izumi G, Higaki T, Otsuki A, Hata A, Hanaoka H, Suzuki H, Terai M, Hamada H, Onouchi Y, Ebata R, Terauchi M, Fujii Y, Sato T, Aoyagi R, Hanawa M, Fujiwara T, Fuse S, Okajima Y, Kurotobi S (2019) KAICA trial Prevention of coronary artery abnormalities in patients with Kawasaki disease predicted to be at increased risk of non-response to intravenous immunoglobulin (KAICA): a randomised controlled, open-label, blinded-endpoints, Phase 3 Trial. Lancet 393:1128–1137

    Article  CAS  Google Scholar 

  9. Ae R, Makino N, Kosami K, Kuwabara M, Matsubara Y, Nakamura Y (2020) Epidemiology, treatments, and cardiac complications in patients with Kawasaki disease: the nationwide survey in Japan, 2017–2018. J Pediatr 225:23–29

    Article  Google Scholar 

  10. McCrindle BW, Rowley AH, Newburger JW, Burns JC, Bolger AF, Gewitz M et al (2017) Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association. Circulation 135:e927–e999

    Article  Google Scholar 

  11. Kobayashi T, Fuse S, Sakamoto N, Mikami M, Ogawa S, Hamaoka K, Arakaki Y, Nakamura T, Nagasawa H, Kato T, Jibiki T, Iwashima S, Yamakawa M, Ohkubo T, Shimoyama S, Aso K, Sato S, Saji T (2016)Z-score Project Investigators. A new Z-score curve of the coronary arterial internal diameter using the Lambda-Mu-Sigma method in a pediatric population. J Am Soc Echocardiogr 29:794–801

    Article  Google Scholar 

  12. McCrindle BW, Rowley AH, Newburger JW, Burns JC, Bolger AF, Gewitz M, Baker AL, Jackson MA, Takahashi M, Shah PB, Kobayashi T, Wu MH, Saji TT, Pahl E (2017) Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association. Circulation 135:e927–e999

    Article  Google Scholar 

  13. Dominguez SR, Anderson MS, El-Adawy M, Glodé MP (2012) Preventing coronary artery abnormalities: a need for earlier diagnosis and treatment of Kawasaki disease. Pediatr Infect Dis J 31:1217–1220

    Article  Google Scholar 

  14. Son MBF, Gauvreau K, Kim S, Tang A, Dedeoglu F, Fulton DR, Lo MS, Baker AL, Sundel RP, Newburger JW (2017) Predicting coronary artery aneurysms in Kawasaki disease at a North American Center: an assessment of baseline Z-scores. J Am Heart Assoc 6:e005378

    Article  Google Scholar 

  15. Dionne A, Burns JC, Dahdah N, Tremoulet AH, Gauvreau K, de Ferranti SD, Baker AL, Son MB, Gould P, Fournier A, Newburger JW, Friedman KG (2019) Treatment intensification in patients with Kawasaki disease and coronary aneurysm at diagnosis. Pediatrics 143:e20183341

    Article  Google Scholar 

  16. McCrindle BW, Li JS, Minich LL, Colan SD, Atz AM, Takahashi M, Vetter VL, Gersony WM, Mitchell PD, Newburger JW (2007) Pediatric Heart Network Investigators: coronary artery involvement in children with Kawasaki disease: risk factors from analysis of serial normalized measurements. Circulation 116:174–179

    Article  Google Scholar 

  17. Ayusawa M, Sonobe T, Uemura S, Ogawa S, Nakamura Y, Kiyosawa N, Ishii M, Harada K (2005) Revision of diagnostic guidelines for Kawasaki disease (the 5th revised edition). Pediatr Int 47:232–234

    Article  Google Scholar 

  18. Kobayashi T, Inoue Y, Takeuchi K, Okada Y, Tamura K, Tomomasa T, Kobayashi T, Morikawa A (2006) Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease. Circulation 113:2606–2612

    Article  Google Scholar 

  19. Egami K, Muta H, Ishii M, Suda K, Sugahara Y, Iemura M, Matsuishi T (2006) Prediction of resistance to intravenous immunoglobulin treatment in patients with Kawasaki disease. J Pediatr 149:237–240

    Article  CAS  Google Scholar 

  20. Sano T, Kurotobi S, Matsuzaki K, Yamamoto T, Maki I, Miki K, Kogaki S, Hara J (2007) Prediction of non-responsiveness to standard high-dose gamma-globulin therapy in patients with acute Kawasaki disease before starting initial treatment. Eur J Pediatr 166:131–137

    Article  CAS  Google Scholar 

  21. Harada K (1991) Intravenous gamma-globulin treatment in Kawasaki disease. Acta Paediatr Jpn 33:805–810

    Article  CAS  Google Scholar 

  22. Ge J, Erbel R, Gerber T, Görge G, Koch L, Haude M, Meyer J (1994) Intravascular ultrasound imaging of angiographically normal coronary arteries: a prospective study in vivo. Br Heart J 71:572–578

    Article  CAS  Google Scholar 

  23. Z score calculator of coronary arterial diameter. http://raise.umin.jp/zsp/calculator/#sub. Accessed 31 July 2020

  24. Takahashi K, Oharaseki T, Yokouchi Y, Naoe S, Saji T (2013) Kawasaki disease: basic and pathological findings. Clin Exp Nephrol 17:690–693

    Article  Google Scholar 

  25. Fuse S, Mori T, Kuroiwa Y, Hirakawa S (2017) On what day of illness does the dilatation of coronary arteries in patients with Kawasaki disease begin? Circ J 82:247–250

    Article  Google Scholar 

Download references

Funding

This work was supported by Grants-in-Aid for Scientific Research (KAKENHI 20K08189) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT).

Author information

Authors and Affiliations

Authors

Contributions

Takayuki Suzuki collected data, designed the study, and drafted initial analyses and manuscript. Nobuyuki Kakimoto, Tomohiro Suenaga, and Takashi Takeuchi were responsible for echocardiography examination and data collecting. Tomoya Tsuchihashi, Shoichi Shibuta, Naomi Kitano, and Hiroyuki Suzuki contributed to the study design and data analysis and revised the manuscript. All authors read and approved the final manuscript

Corresponding author

Correspondence to Hiroyuki Suzuki.

Ethics declarations

Ethics approval

This study was approved by the ethics committee of Wakayama Medical University (No: 2801).

Consent to participate

Informed consent was waived, because all data were de-identified.

Consent for publication

N/A

Conflict of interest

The authors declare no competing interests.

Additional information

Communicated by Peter de Winter

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Suzuki, T., Kakimoto, N., Tsuchihashi, T. et al. Z-score is a possible predictor of the risk of coronary artery lesion development in patients with Kawasaki disease in Japan. Eur J Pediatr 180, 2797–2805 (2021). https://doi.org/10.1007/s00431-021-04006-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00431-021-04006-1

Keywords

Navigation